High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia ; volume:13 ; number:1 ; day:11 ; month:7 ; year:2020 ; pages:1-4 ; date:12.2020
BMC Research Notes / Biomed Central; 13, Heft 1 (11.7.2020), 1-4, 12.2020
- Urheber
-
Butsashvili, Maia
Gvinjilia, Lia
Kamkamidze, George
Metreveli, David
Dvali, Shorena
Rukhadze, Tamar
Gamkrelidze, Amiran
Nasrullah, Muazzam
Shadaker, Shaun
Morgan, Juliette
Averhoff, Francisco
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-020-05173-4
- URN
-
urn:nbn:de:101:1-2020090919231125998258
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Butsashvili, Maia
- Gvinjilia, Lia
- Kamkamidze, George
- Metreveli, David
- Dvali, Shorena
- Rukhadze, Tamar
- Gamkrelidze, Amiran
- Nasrullah, Muazzam
- Shadaker, Shaun
- Morgan, Juliette
- Averhoff, Francisco
- SpringerLink (Online service)
Ähnliche Objekte (12)
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
HCV resistance
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
HCV resistance
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
HCV
Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
HCV resistance
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b